BlackRock’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,296,333
Closed -$26.2M 5940
2021
Q3
$26.2M Buy
4,296,333
+2,278
+0.1% +$14.2K ﹤0.01% 3102
2021
Q2
$35.3M Sell
4,294,055
-222,061
-5% -$1.89M ﹤0.01% 2930
2021
Q1
$40.4M Buy
4,516,116
+176,792
+4% +$2.03M ﹤0.01% 2761
2020
Q4
$50.1M Buy
4,339,324
+216,183
+5% +$2.51M ﹤0.01% 2470
2020
Q3
$42.9M Buy
4,123,141
+691,089
+20% +$8.47M ﹤0.01% 2390
2020
Q2
$45.1M Buy
3,432,052
+461,242
+16% +$4.78M ﹤0.01% 2311
2020
Q1
$23.4M Sell
2,970,810
-93,842
-3% -$1.41M ﹤0.01% 2521
2019
Q4
$63.4M Buy
3,064,652
+55,653
+2% +$939K ﹤0.01% 2216
2019
Q3
$41.2M Buy
3,008,999
+230,135
+8% +$2.73M ﹤0.01% 2417
2019
Q2
$34.2M Sell
2,778,864
-11,573
-0.4% -$134K ﹤0.01% 2546
2019
Q1
$34.8M Sell
2,790,437
-67,594
-2% -$903K ﹤0.01% 2486
2018
Q4
$32.4M Sell
2,858,031
-10,957
-0.4% -$172K ﹤0.01% 2468
2018
Q3
$53.7M Buy
2,868,988
+39,511
+1% +$908K ﹤0.01% 2338
2018
Q2
$73.1M Buy
2,829,477
+217,510
+8% +$5.64M ﹤0.01% 2131
2018
Q1
$58.5M Sell
2,611,967
-39,019
-1% -$952K ﹤0.01% 2181
2017
Q4
$66.4M Buy
2,650,986
+392,055
+17% +$9.6M ﹤0.01% 2105
2017
Q3
$54.6M Buy
2,258,931
+60,846
+3% +$1.43M ﹤0.01% 2235
2017
Q2
$44.4M Buy
2,198,085
+85,426
+4% +$1.78M ﹤0.01% 2331
2017
Q1
$56.9M Buy
2,112,659
+2,110,357
+91,675% +$43.1M ﹤0.01% 2138
2016
Q4
$44K Buy
2,302
+363
+19% +$6.94K ﹤0.01% 2996
2016
Q3
$38K Sell
1,939
-79
-4% -$1.34K ﹤0.01% 3094
2016
Q2
$31K Buy
2,018
+853
+73% +$10.7K ﹤0.01% 3130
2016
Q1
$11K Buy
1,165
+654
+128% +$7.93K ﹤0.01% 3132
2015
Q4
$10K Buy
511
+353
+223% +$6.13K ﹤0.01% 2903
2015
Q3
$2K Hold
158
﹤0.01% 3172
2015
Q2
$3K Hold
158
﹤0.01% 3197
2015
Q1
$4K Buy
+158
New +$3.66K ﹤0.01% 3080